{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T01:05:22Z","timestamp":1785114322928,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s43032-019-00032-5","type":"journal-article","created":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T19:03:47Z","timestamp":1581707027000},"page":"355-363","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Evaluation of Syndecan-1 as a Novel Biomarker for Adverse Pregnancy Outcomes"],"prefix":"10.1007","volume":"27","author":[{"given":"Elizabeth T.","family":"Greeley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burton","family":"Rochelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Krantz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangying","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan B.","family":"Carmichael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Ashour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seunghyun","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Augustine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine N.","family":"Metz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,6]]},"reference":[{"key":"32_CR1","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1080\/14767058.2016.1263295","volume":"30","author":"JJA van Esch","year":"2017","unstructured":"van Esch JJA, van Heijst AF, de Haan AFJ, van der Heijden OWH. Early-onset preeclampsia is associated with perinatal mortality and severe neonatal morbidity. J Matern Fetal Neonatal Med. 2017;30:2789\u201394.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"32_CR2","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1097\/GCO.0b013e3283404e89","volume":"22","author":"EK Main","year":"2010","unstructured":"Main EK. Maternal mortality: new strategies for measurement and prevention. Curr Opin Obstet Gynecol. 2010;22:511\u20136.","journal-title":"Curr Opin Obstet Gynecol"},{"key":"32_CR3","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1055\/s-0030-1270342","volume":"37","author":"JA van der Post","year":"2011","unstructured":"van der Post JA, Lok CA, Boer K, Sturk A, Sargent IL, Nieuwland R. The functions of microparticles in pre-eclampsia. Semin Thromb Hemost. 2011;37:146\u201352.","journal-title":"Semin Thromb Hemost"},{"key":"32_CR4","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.preghy.2012.01.001","volume":"2","author":"JM Roberts","year":"2012","unstructured":"Roberts JM, Escudero C. The placenta in preeclampsia. Pregnancy Hypertens. 2012;2:72\u201383.","journal-title":"Pregnancy Hypertens"},{"key":"32_CR5","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S0140-6736(05)17987-2","volume":"365","author":"B Sibai","year":"2005","unstructured":"Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005;365:785\u201399.","journal-title":"Lancet"},{"key":"32_CR6","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1056\/NEJMoa031884","volume":"350","author":"RJ Levine","year":"2004","unstructured":"Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350:672\u201383.","journal-title":"N Engl J Med"},{"key":"32_CR7","doi-asserted-by":"publisher","first-page":"S123","DOI":"10.1016\/j.ajog.2015.06.038","volume":"213","author":"EJ Su","year":"2015","unstructured":"Su EJ. Role of the fetoplacental endothelium in fetal growth restriction with abnormal umbilical artery Doppler velocimetry. Am J Obstet Gynecol. 2015;213:S123\u201330.","journal-title":"Am J Obstet Gynecol"},{"key":"32_CR8","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1016\/S0002-9440(10)64127-2","volume":"158","author":"F Lyall","year":"2001","unstructured":"Lyall F, Bulmer JN, Duffie E, Cousins F, Theriault A, Robson SC. Human trophoblast invasion and spiral artery transformation: the role of PECAM-1 in normal pregnancy, preeclampsia, and fetal growth restriction. Am J Pathol. 2001;158:1713\u201321.","journal-title":"Am J Pathol"},{"key":"32_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1095\/biolreprod.102.014977","volume":"69","author":"P Kaufmann","year":"2003","unstructured":"Kaufmann P, Black S, Huppertz B. Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol Reprod. 2003;69:1\u20137.","journal-title":"Biol Reprod"},{"key":"32_CR10","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.diabres.2018.05.002","volume":"145","author":"LC Poon","year":"2018","unstructured":"Poon LC, McIntyre HD, Hyett JA, da Fonseca EB, Hod M, Pregnancy F, et al. The first-trimester of pregnancy - a window of opportunity for prediction and prevention of pregnancy complications and future life. Diabetes Res Clin Pract. 2018;145:20\u201330.","journal-title":"Diabetes Res Clin Pract"},{"key":"32_CR11","doi-asserted-by":"publisher","first-page":"807196","DOI":"10.1155\/2014\/807196","volume":"2014","author":"SC Kane","year":"2014","unstructured":"Kane SC, Costa Fda S, Brennecke S. First trimester biomarkers in the prediction of later pregnancy complications. Biomed Res Int. 2014;2014:807196.","journal-title":"Biomed Res Int"},{"key":"32_CR12","doi-asserted-by":"crossref","unstructured":"ACOG Committee Opinion No. 743: Low-dose aspirin use during pregnancy. Obstet Gynecol. 2018;132:e44\u201352.","DOI":"10.1097\/AOG.0000000000002708"},{"key":"32_CR13","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1038\/nrm1257","volume":"4","author":"JR Couchman","year":"2003","unstructured":"Couchman JR. Syndecans: proteoglycan regulators of cell-surface microdomains? Nat Rev Mol Cell Biol. 2003;4:926\u201337.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"32_CR14","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.biocel.2006.10.014","volume":"39","author":"AN Alexopoulou","year":"2007","unstructured":"Alexopoulou AN, Multhaupt HA, Couchman JR. Syndecans in wound healing, inflammation and vascular biology. Int J Biochem Cell Biol. 2007;39:505\u201328.","journal-title":"Int J Biochem Cell Biol"},{"key":"32_CR15","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0143-4004(98)90004-2","volume":"19","author":"V Jokimaa","year":"1998","unstructured":"Jokimaa V, Inki P, Kujari H, Hirvonen O, Ekholm E, Anttila L. Expression of syndecan-1 in human placenta and decidua. Placenta. 1998;19:157\u201363.","journal-title":"Placenta"},{"key":"32_CR16","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/pd.2908","volume":"32","author":"A Schmedt","year":"2012","unstructured":"Schmedt A, Gotte M, Heinig J, Kiesel L, Klockenbusch W, Steinhard J. Evaluation of placental syndecan-1 expression in early pregnancy as a predictive fetal factor for pregnancy outcome. Prenat Diagn. 2012;32:131\u20137.","journal-title":"Prenat Diagn"},{"key":"32_CR17","doi-asserted-by":"publisher","first-page":"e0157608","DOI":"10.1371\/journal.pone.0157608","volume":"11","author":"RE Gandley","year":"2016","unstructured":"Gandley RE, Althouse A, Jeyabalan A, Bregand-White JM, McGonigal S, Myerski AC, et al. Low soluble syndecan-1 precedes preeclampsia. PLoS One. 2016;11:e0157608.","journal-title":"PLoS One"},{"key":"32_CR18","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1515\/jpm-2013-0097","volume":"42","author":"N Heyer-Chauhan","year":"2014","unstructured":"Heyer-Chauhan N, Ovbude IJ, Hills AA, Sullivan MH, Hills FA. Placental syndecan-1 and sulphated glycosaminoglycans are decreased in preeclampsia. J Perinat Med. 2014;42:329\u201338.","journal-title":"J Perinat Med"},{"key":"32_CR19","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1097\/SLA.0b013e318226113d","volume":"254","author":"PI Johansson","year":"2011","unstructured":"Johansson PI, Stensballe J, Rasmussen LS, Ostrowski SR. A high admission syndecan-1 level, a marker of endothelial glycocalyx degradation, is associated with inflammation, protein C depletion, fibrinolysis, and increased mortality in trauma patients. Ann Surg. 2011;254:194\u2013200.","journal-title":"Ann Surg"},{"key":"32_CR20","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12967-015-0481-5","volume":"13","author":"E Rahbar","year":"2015","unstructured":"Rahbar E, Cardenas JC, Baimukanova G, Usadi B, Bruhn R, Pati S, et al. Endothelial glycocalyx shedding and vascular permeability in severely injured trauma patients. J Transl Med. 2015;13:117.","journal-title":"J Transl Med"},{"key":"32_CR21","unstructured":"American College of Obstetricians and\u00a0Gynecologists, Task Force on Hypertension in Pregnancy: Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists\u2019 Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013;122:1122\u201331."},{"key":"32_CR22","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/pd.2440","volume":"30","author":"LC Poon","year":"2010","unstructured":"Poon LC, Stratieva V, Piras S, Piri S, Nicolaides KH. Hypertensive disorders in pregnancy: combined screening by uterine artery Doppler, blood pressure and serum PAPP-A at 11-13 weeks. Prenat Diagn. 2010;30:216\u201323.","journal-title":"Prenat Diagn"},{"key":"32_CR23","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1002\/uog.17455","volume":"49","author":"N O\u2019Gorman","year":"2017","unstructured":"O\u2019Gorman N, Wright D, Poon LC, Rolnik DL, Syngelaki A, de Alvarado M, et al. Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks\u2019 gestation: comparison with NICE guidelines and ACOG recommendations. Ultrasound Obstet Gynecol. 2017;49:756\u201360.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"32_CR24","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1097\/01.AOG.0000172419.37410.eb","volume":"106","author":"L Dugoff","year":"2005","unstructured":"Dugoff L, Hobbins JC, Malone FD, Vidaver J, Sullivan L, Canick JA, et al. Quad screen as a predictor of adverse pregnancy outcome. Obstet Gynecol. 2005;106:260\u20137.","journal-title":"Obstet Gynecol"},{"key":"32_CR25","doi-asserted-by":"publisher","first-page":"619 e1","DOI":"10.1016\/j.ajog.2015.11.016","volume":"214","author":"DM Gallo","year":"2016","unstructured":"Gallo DM, Wright D, Casanova C, Campanero M, Nicolaides KH. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 19-24 weeks\u2019 gestation. Am J Obstet Gynecol. 2016;214:619 e1\u2013e17.","journal-title":"Am J Obstet Gynecol"},{"key":"32_CR26","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/1477-7827-8-133","volume":"8","author":"DM Baston-Bust","year":"2010","unstructured":"Baston-Bust DM, Gotte M, Janni W, Krussel JS, Hess AP. Syndecan-1 knock-down in decidualized human endometrial stromal cells leads to significant changes in cytokine and angiogenic factor expression patterns. Reprod Biol Endocrinol. 2010;8:133.","journal-title":"Reprod Biol Endocrinol"},{"key":"32_CR27","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1067\/mob.2000.107320","volume":"183","author":"VI Jokimaa","year":"2000","unstructured":"Jokimaa VI, Kujari HP, Ekholm EM, Inki PL, Anttila L. Placental expression of syndecan 1 is diminished in preeclampsia. Am J Obstet Gynecol. 2000;183:1495\u20138.","journal-title":"Am J Obstet Gynecol"},{"key":"32_CR28","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.ajpath.2011.10.023","volume":"180","author":"A Chui","year":"2012","unstructured":"Chui A, Zainuddin N, Rajaraman G, Murthi P, Brennecke SP, Ignjatovic V, et al. Placental syndecan expression is altered in human idiopathic fetal growth restriction. Am J Pathol. 2012;180:693\u2013702.","journal-title":"Am J Pathol"},{"key":"32_CR29","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1096\/fj.02-0739rev","volume":"17","author":"M Gotte","year":"2003","unstructured":"Gotte M. Syndecans in inflammation. FASEB J. 2003;17:575\u201391.","journal-title":"FASEB J"},{"key":"32_CR30","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.jss.2009.04.034","volume":"165","author":"J Steppan","year":"2011","unstructured":"Steppan J, Hofer S, Funke B, Brenner T, Henrich M, Martin E, et al. Sepsis and major abdominal surgery lead to flaking of the endothelial glycocalix. J Surg Res. 2011;165:136\u201341.","journal-title":"J Surg Res"},{"key":"32_CR31","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s00428-013-1426-0","volume":"463","author":"S Szabo","year":"2013","unstructured":"Szabo S, Xu Y, Romero R, Fule T, Karaszi K, Bhatti G, et al. Changes of placental syndecan-1 expression in preeclampsia and HELLP syndrome. Virchows Arch. 2013;463:445\u201358.","journal-title":"Virchows Arch"},{"key":"32_CR32","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1177\/1933719112453508","volume":"20","author":"KF Hofmann-Kiefer","year":"2013","unstructured":"Hofmann-Kiefer KF, Knabl J, Martinoff N, Schiessl B, Conzen P, Rehm M, et al. Increased serum concentrations of circulating glycocalyx components in HELLP syndrome compared to healthy pregnancy: an observational study. Reprod Sci. 2013;20:318\u201325.","journal-title":"Reprod Sci"},{"key":"32_CR33","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1016\/j.febslet.2012.05.037","volume":"586","author":"MJ Kwon","year":"2012","unstructured":"Kwon MJ, Jang B, Yi JY, Han IO, Oh ES. Syndecans play dual roles as cell adhesion receptors and docking receptors. FEBS Lett. 2012;586:2207\u201311.","journal-title":"FEBS Lett"},{"key":"32_CR34","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/carcin\/bgp001","volume":"30","author":"V Nikolova","year":"2009","unstructured":"Nikolova V, Koo CY, Ibrahim SA, Wang Z, Spillmann D, Dreier R, et al. Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression. Carcinogenesis. 2009;30:397\u2013407.","journal-title":"Carcinogenesis"},{"key":"32_CR35","doi-asserted-by":"publisher","first-page":"53 e1","DOI":"10.1016\/j.ajog.2013.03.017","volume":"209","author":"SE Maynard","year":"2013","unstructured":"Maynard SE, Crawford SL, Bathgate S, Yan J, Robidoux L, Moore M, et al. Gestational angiogenic biomarker patterns in high risk preeclampsia groups. Am J Obstet Gynecol. 2013;209:53 e1\u20139.","journal-title":"Am J Obstet Gynecol"}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-019-00032-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s43032-019-00032-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-019-00032-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T01:04:45Z","timestamp":1609808685000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s43032-019-00032-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["32"],"URL":"https:\/\/doi.org\/10.1007\/s43032-019-00032-5","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"value":"1933-7191","type":"print"},{"value":"1933-7205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"4 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"DAK and JBC are employees of Eurofins NTD, LLC. The remaining authors, ETG, BR, XX, SA, SW, SA, and CNM, report no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This study was approved by the Northwell Health Office of the Human Research Protection Program (IRB no. 14-340B).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research Ethics"}}]}}